{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:18:00Z","timestamp":1768922280669,"version":"3.49.0"},"reference-count":29,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000028","name":"Institute of Circulatory and Respiratory Health","doi-asserted-by":"publisher","award":["Early career investigator award in Circulatory and"],"award-info":[{"award-number":["Early career investigator award in Circulatory and"]}],"id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2023,6,30]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to assess the incremental prognostic value of N-terminal-pro-B-type natriuretic peptide (Nt-proBNP) for risk stratification in mixed aortic valve disease (MAVD) patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included 556 (73\u00b112 years, 37% women) consecutive patients with at least a moderate aortic stenosis (AS) or aortic regurgitation (AR) lesion with a concomitant AS or AR of any severity in whom Nt-proBNP was measured and expressed as its ratio (measured Nt-proBNP divided by the upper limit of normal Nt-proBNP for age and sex). The primary endpoint was all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Baseline median Nt-proBNP ratio was 3.8 (IQR: 1.5\u201311.3), and the median follow-up was 5.6 years (4.8\u20136.1). Early aortic valve replacement (AVR) was performed within 3 months in 423 (76%) patients, while 133 (24%) remained initially under medical treatment. In comprehensive multivariable analyses, Nt-proBNP ratio was significantly associated with excess mortality (continuous variable: HR (95% CI): 1.24 (1.04 to 1.47), p=0.02; Nt-proBNP ratio \u22653: 2.41 (1.33 to 4.39), p=0.004). The independent prognostic value was also observed in patients with severe or non-severe AS\/AR, and those treated by early-AVR (all p&lt;0.04). Nt-proBNP ratio as continuous and dichotomic (\u22653) variables showed incremental prognostic value (all net reclassification index &gt;0.42, all p\u22640.008). After early-AVR, Nt-proBNP ratio \u22653 was associated with higher 30-day mortality (9 (4%) vs 1 (0.5%), p=0.02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this series of MAVD patients, Nt-proBNP ratio was a powerful predictor of early and long-term mortality, even in patients with both non-severe AS\/AR. Moreover, early-AVR may be an option for patients with Nt-proBNP ratio \u22653. Further randomised studies are needed to validate this last point.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2023-002361","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T23:40:49Z","timestamp":1689810049000},"page":"e002361","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-2636","authenticated-orcid":false,"given":"J\u00e9r\u00e9my","family":"Bernard","sequence":"first","affiliation":[{"name":"Cardiology, Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec - Universit\u00e9 Laval, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Jean","sequence":"additional","affiliation":[{"name":"Cardiology, Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec - Universit\u00e9 Laval, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bienjonetti-Boudreau","sequence":"additional","affiliation":[{"name":"Cardiology, Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec - Universit\u00e9 Laval, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Jacques","sequence":"additional","affiliation":[{"name":"Cardiac Surgery, Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec - Universit\u00e9 Laval, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Tastet","sequence":"additional","affiliation":[{"name":"Cardiology, Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec - Universit\u00e9 Laval, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Salaun","sequence":"additional","affiliation":[{"name":"Cardiology, Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec - Universit\u00e9 Laval, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8924-740X","authenticated-orcid":false,"given":"Marie-Annick","family":"Clavel","sequence":"additional","affiliation":[{"name":"Cardiology, Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec - Universit\u00e9 Laval, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"2025081709573746000_10.2.e002361.1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310894"},{"key":"2025081709573746000_10.2.e002361.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.035"},{"key":"2025081709573746000_10.2.e002361.3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/24748706.2020.1817643","article-title":"Mixed aortic valve disease: A diagnostic challenge, a Prognostic threat","volume":"4","author":"Unger","year":"2020","journal-title":"Structural Heart"},{"key":"2025081709573746000_10.2.e002361.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.04.013"},{"key":"2025081709573746000_10.2.e002361.5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijcard.2016.11.237","article-title":"Predictor of left ventricular dysfunction after aortic valve replacement in mixed aortic valve disease","volume":"228","author":"Egbe","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025081709573746000_10.2.e002361.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw079"},{"key":"2025081709573746000_10.2.e002361.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.509"},{"key":"2025081709573746000_10.2.e002361.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.06.020"},{"key":"2025081709573746000_10.2.e002361.9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4244\/EIJ-D-17-00328","article-title":"Transcatheter aortic valve implantation for mixed versus pure Stenotic aortic valve disease","volume":"13","author":"Abdelghani","year":"2017","journal-title":"EuroIntervention"},{"key":"2025081709573746000_10.2.e002361.10","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.21037\/jtd.2018.06.128","article-title":"Outcomes of surgical aortic valve replacement for mixed aortic valve disease","volume":"10","author":"Philip","year":"2018","journal-title":"J Thorac Dis"},{"key":"2025081709573746000_10.2.e002361.11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014591","article-title":"Long-term outcomes in patients with mixed aortic valve disease and preserved left ventricular ejection fraction","volume":"9","author":"Isaza","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025081709573746000_10.2.e002361.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.581"},{"key":"2025081709573746000_10.2.e002361.13","doi-asserted-by":"crossref","unstructured":"Nakatsuma K , Taniguchi T , Morimoto T , et al . n.d. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis. Heart:heartjnl\u20132018 doi:10.1136\/heartjnl-2018-313746","DOI":"10.1136\/heartjnl-2018-313746"},{"key":"2025081709573746000_10.2.e002361.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.07.016"},{"key":"2025081709573746000_10.2.e002361.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.07.174"},{"key":"2025081709573746000_10.2.e002361.16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-312303"},{"key":"2025081709573746000_10.2.e002361.17","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-320501"},{"key":"2025081709573746000_10.2.e002361.18","first-page":"33","article-title":"Aortic stenosis with other concomitant valvular disease: aortic regurgitation, mitral regurgitation, mitral stenosis, or Tricuspid regurgitation","volume":"38","author":"Unger","year":"2020","journal-title":"Cardiol Clin"},{"key":"2025081709573746000_10.2.e002361.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.549"},{"key":"2025081709573746000_10.2.e002361.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.029"},{"key":"2025081709573746000_10.2.e002361.21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ehjci\/jex148","article-title":"Role of diastolic function indices in the risk stratification of patients with mixed aortic valve disease","volume":"19","author":"Egbe","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025081709573746000_10.2.e002361.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.02.031"},{"key":"2025081709573746000_10.2.e002361.23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamacardio.2021.5916","article-title":"Association of annual N-terminal pro-brain natriuretic peptide measurements with clinical events in patients with asymptomatic Nonsevere aortic stenosis: A post hoc Substudy of the SEAS trial","volume":"7","author":"Hadziselimovic","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025081709573746000_10.2.e002361.24","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/ehf2.13946","article-title":"Prognostic relevance of B-type natriuretic peptide in patients with moderate mixed aortic valve disease","volume":"9","author":"Onishi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2025081709573746000_10.2.e002361.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02059-4"},{"key":"2025081709573746000_10.2.e002361.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.07.014"},{"key":"2025081709573746000_10.2.e002361.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.074"},{"key":"2025081709573746000_10.2.e002361.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.04.023"},{"key":"2025081709573746000_10.2.e002361.29","first-page":"1004","article-title":"The role of Extravalvular cardiac damage staging in aortic valve disease management","volume":"37","author":"Tastet","year":"2021","journal-title":"Can J Cardiol"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2023-002361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:57:44Z","timestamp":1755449864000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2023-002361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,7,19]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/openhrt-2023-002361"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2023-002361","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}